Hematology/Oncology

Top Story

Two senators reach bipartisan deal to save health insurance subsidies

October 17, 2017

Two senators have struck a bipartisan deal to temporarily preserve subsidies for health insurance companies set to be scrapped by President Donald J. Trump, The New York Times reports.

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized…

California law may minimally impact drug pricing transparency

October 17, 2017
California Gov. Jerry Brown approved legislation that will require pharmaceutical companies to give the state advanced notice of, as well as justify, dramatic drug…
Blog

BLOG: Gainsharing/co-management is a great opportunity for physicians, hospitals

October 17, 2017
As a physician, you have a unique ability to make the delivery of health care more efficient and save hospitals money, which ultimately has the effect of lowering health…
FDA News

FDA grants priority review to Opdivo for resected, high-risk melanoma

October 17, 2017
The FDA granted priority review to nivolumab for the treatment of patients with melanoma who are at high risk for disease recurrence following complete surgical…
More Headlines »
CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms…
More »
Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement